ANGPTL4 — the link binding obesity and glucose intolerance
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Janssen, A. W. F., Katiraei, S., Bartosinska, B., Eberhard, D., Willems van Dijk, K., & Kersten, S. (2018) · Diabetologia · doi:10.1007/s00125-018-4583-5 · Cited by 96 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Leal, L. G., Lopes, M. A., & Batista, M. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01307 · Cited by 382 · see citing works
“However, even with published data indicating a role for ANGPTL4 in obesity, and glucose intolerance (Morris, 2018), this protein is still poorly studied and there is much about its therapeutic role that needs to be further investigated.”
BackgroundSarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83 · see citing works
Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review
Zecheng, L., Donghai, L., Runchuan, G., Yuan, Q., Qi, J., Yijia, Z., Shuaman, R., Xiaoqi, L., Yi, W., Ni, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110803 · Cited by 69 · see citing works
Huang, S.-F., Zhao, G., Peng, X., & Ye, W.-C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.770163 · Cited by 48 · see citing works
Guo, J., Zhang, M., Wang, H., Li, N., Lu, Z., Li, L., Hui, S., & Xu, H. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14063 · Cited by 44 · see citing works
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
Srivastava, S. P., Zhou, H., Shenoi, R., Morris, M., Lainez, B., Goedeke, L., Rajendran, B. K., Setia, O., Aryal, B. K., Kanasaki, K., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6068 · Cited by 40 · see citing works
ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a
Jung, K. H., Son, M. K., YAN, H. H., Fang, Z., Kim, J.-Y., Kim, S. J., Park, J. H., Lee, J. E., Yoon, Y., Seo, M.-S., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911222 · Cited by 33 · see citing works
Jia, Y., Liu, Y., Wu, Y., Feng, C., Zhang, H., Ren, F., & Liu, H. (2024) · Food & Function · doi:10.1039/d4fo00585f · Cited by 27 · see citing works
ANGPTL4 attenuates palmitic acid-induced endothelial cell injury by increasing autophagy
Zhan, W., Tian, W., Zhang, W., Tian, H., & Sun, T. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110410 · Cited by 22 · see citing works
Adropin and glucagon-like peptide-2 are associated with glucose metabolism in obese children
Chen, R., Yuan, X., Ouyang, Q., Lin, X., Ai, Z., Zhang, Y., & Yang, X. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-019-00296-6 · Cited by 17 · see citing works
ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity
Li, N., Wang, X., Lin, R., Yang, F., Chang, H.-C., Gu, X., Shu, J., Liu, G., Yu, Y., Wei, W., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106741 · Cited by 15 · see citing works
Liu, Y., Ma, Q., Khan, M. Z., Wang, M., Xiang, F., Zhang, X., Kou, X., Li, S., Wang, C., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072892 · Cited by 12 · see citing works
Xiang, X., Han, S., Xu, D., Chen, Q., Ji, R., Zhao, Z., Du, J., Mai, K., & Ai, Q. (2021) · British Journal Of Nutrition · doi:10.1017/s000711452100386x · Cited by 9 · see citing works
Kuo, C., Wang, S., Juan, H.-C., Chen, S., Kuo, C., Kuo, H., Lin, S., & Li, H. (2024) · BioFactors · doi:10.1002/biof.2076 · Cited by 8 · see citing works
Tong, Z., Peng, J., Lan, H., Sai, W.-W., Li, Y., Xie, J., Tan, Y., Zhang, W., Zhong, M., & Wang, Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02739-z · Cited by 6 · see citing works
Yoshiji, S., Lu, T., Butler‐Laporte, G., Carrasco-Zanini, J., Chen, Y., Liang, K. Y. H., Willett, J., Su, C., Wang, S., Adra, D., et al. (2023) · medRxiv · doi:10.1101/2023.04.19.23288706 · Cited by 5 · see citing works
Li, S., Liu, Y., Wang, Q., Zhu, Z., Li, W., Li, C., Fei, F., Liu, B., & Shao, C. (2025) · Marine Biotechnology · doi:10.1007/s10126-025-10423-2 · Cited by 4 · see citing works
Cao, L., & Zhu, W. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1795452 · Cited by 3 · see citing works
Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney diseasePreprint
Srivastava, S. P., Zhou, H., Shenoi, R., Morris, M., Lainez, B., Takagaki, Y., Rajendran, B. K., Setia, O., Aryal, B. K., Kanasaki, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.652142 · Cited by 2 · see citing works
Early-life proteomic and microbiome features signal obesity risk across 26 years of follow-up
Ahrens, A. P., Dias, R., Hyötyläinen, T., White, P. A., Orešič, M., Triplett, E. W., & Ludvigsson, J. (2026) · mSystems · doi:10.1128/msystems.01424-25
- Authors
- Morris, A.
- Corresponding author
- Morris, Alan
- ORCID
- Morris, Alan
- Venue
- Nature Reviews Endocrinology
- Published
- 2018-04-03
- Volume
- 14
- Issue
- 5
- Pages
- 251-251
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2795937591
- Cited by
- 20
- References
- 1
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 1
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- ANGPTL4, angiopoietin-like proteins, obesity, impaired glucose tolerance, lipoprotein lipase, pancreatic lipase, lipid metabolism, cardiometabolic dysfunction, lipolysis, therapeutic target
- MeSH terms
- Gastrointestinal Microbiome, Angiopoietin-Like Protein 4, Animals, Diet, Humans, Obesity, Glucose Intolerance, Angiopoietins, Mice, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review